K&F’s first post-pandemic jury trial resulted in a $10.6 million verdict for the widow of a mesothelioma victim.

Zantac lawsuits filed by veterans

On Behalf of | Apr 28, 2021 | Zantac Recall

Zantac, or ranitidine, is a medication that has antihistamine and antacid properties. It’s often used by people who deal with ulcers, acid reflux or other similar issues. In recent months, it’s been reported that Zantac is linked to the development of cancer. This has led to recalls and even civil actions. People in Ohio should be aware of some of the lawsuits that are being filed in relationship to the Zantac recall.

What makes Zantac problematic?

Zantac was used for years because people believed it was safe. However, ranitidine can transform and become a chemical called N-Nitrosodimethylamine, or NDMA, after it’s ingested. NDMA is toxic, and there’s evidence to suggest that this is not new information. It’s very possible that the manufacturers of the drug knew of its harm-causing potential. Documents suggest this may have been true even before ranitidine was approved by the FDA. This is the basis for an increasing number of lawsuits, including some filed by veterans.

Why did so many veterans use Zantac?

Veterans are actually more likely to have the kind of issues that lead to ranitidine use. They are disproportionately affected by the Zantac recall. There seems to be a correlation between conditions like GERD and PTSD. Unfortunately, many veterans struggle with post-traumatic stress disorder. Over the years, the VA has prescribed ranitidine to thousands of veterans. Several of them have been diagnosed with cancers that may be linked to ranitidine.

If you or a loved one was prescribed Zantac, it’s a good idea to contact a lawyer. An experienced attorney may be able to help you understand who to pursue for compensation and how to do that. Your attorney may also explain what damages you might be able to collect.

Archives

$120 Million Settlement

To 15,000 Asbestos Victims

$20 Million Verdict

Mesothelioma

$17 Million Verdict

Mesothelioma

$8.2 Million Verdict

Mesothelioma

White Paper Read Now2
White Paper Read Now